Pharma Industry News Teva submits FDA application for paediatric Tourette syndrome therapy 7 hours agoAdd Commentby David Miller947 Views Ecopipam could become the first new FDA-approved treatment for paediatric Tourette syndrome in over ten years Source: PMLiVE